Evidence map›Paper›PMID 39156179›Full record

ArticleKidney international reports2024

Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients.

Caroline Lamarche, Karthik Tennankore, Lorie Marchitto, William Beabien-Souligny, Rémi Goupil, Annie-Claire Nadeau-Fredette, Lakshman Gunaratnam, Fabrice Mac-Way, Mehdi Benlarbi, Debashree Chatterjee and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Caroline LamarcheCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.
Karthik TennankoreDepartment of Medicine, Dalhousie University, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Lorie MarchittoCentre de Recherche du CHUM, Montréal, Quebec, Canada.
William Beabien-SoulignyDépartement de Médecine, Université de Montréal, Montréal, Quebec, Canada.
Rémi GoupilDépartement de Médecine, Université de Montréal, Montréal, Quebec, Canada.
Annie-Claire Nadeau-FredetteCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.
Lakshman GunaratnamDivision of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Fabrice Mac-WayCentre de recherche du CHU de Québec, Hôtel-Dieu de Québec and Division of Nephrology, Faculty and Department of Medicine, Université Laval, Quebec, Canada.
Mehdi BenlarbiCentre de Recherche du CHUM, Montréal, Quebec, Canada.
Debashree ChatterjeeCentre de Recherche du CHUM, Montréal, Quebec, Canada.
Alexander TomResearch Institute of the McGill University Health Center, Montreal, Quebec, Canada.
Halima MedjahedCentre de Recherche du CHUM, Montréal, Quebec, Canada.
Daniel E KaufmannCentre de Recherche du CHUM, Montréal, Quebec, Canada.
Andrés FinziCentre de Recherche du CHUM, Montréal, Quebec, Canada.
Rita S SuriResearch Institute of the McGill University Health Center, Montreal, Quebec, Canada.
Réseau Néphrologique Québécois (Quebec Renal Network) COVID-19 Study Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39156179
PMCPMC11328573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.